How long do people stay on Mounjaro for weight loss?

Trial duration was 72 weeks: the SURMOUNT-1 study ran for 72 weeks, and that is still the best evidence base for understanding how long meaningful treatment continues.
Weight often returns after stopping: studies in GLP-1 medicines consistently show that a substantial proportion of lost weight returns within a year of discontinuation, which shapes how prescribers think about duration.
There is no fixed licensed maximum: unlike some medicines, Mounjaro's UK licence does not impose a hard time limit, though NICE's NHS criteria carry their own conditions for continuation.
A review at six months matters: NICE guidance recommends reassessing whether treatment is working after six months; less than 5% weight loss at the highest tolerated dose is a signal to reconsider.

Most people in clinical trials used Mounjaro (tirzepatide) for 72 weeks, which is just under a year and a half. Real-world treatment duration varies more widely: some people complete a defined course and stop, others continue long-term because weight tends to return once treatment ends. Mounjaro is a prescription-only medicine; how long you should stay on it is a clinical decision your prescriber makes with you, based on your response, health goals and any comorbidities.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence says about treatment duration and what happens when Mounjaro stops

What the SURMOUNT trials actually tell us about duration

The pivotal SURMOUNT-1 trial, published in the New England Journal of Medicine, randomised 2,539 adults with obesity over 72 weeks. Participants on the highest doses lost around 20–21% of their body weight on average by the end of the study. That 72-week period is not a magic number chosen arbitrarily; it was long enough to see both the active weight-loss phase and a plateau, giving researchers a realistic picture of where the medicine levels off.

What the trial does not tell us is what happens if you stay on it for three or five years, because that data does not yet exist at scale. This is a relatively new medicine in the weight-management space, and longer-term evidence is still accumulating. Prescribers work with what the evidence currently supports, which is why the six-month review point matters so much in practice.

If you want a sense of how quickly results typically show, the pace of weight loss on Mounjaro varies considerably by dose and individual, with most people seeing meaningful change within the first four to eight weeks at a therapeutic dose.

What happens to weight after people stop taking Mounjaro

This is the question most people quietly have but do not always ask. The honest answer, based on data from semaglutide (Wegovy) discontinuation studies and the emerging tirzepatide picture, is that weight regain is common. The biology is straightforward: Mounjaro works by activating gut-hormone receptors that suppress appetite and slow gastric emptying. Once the medicine is no longer present, those signals diminish and appetite returns toward its pre-treatment baseline.

This does not mean treatment has failed. It reflects how obesity works as a chronic condition, not a temporary one. Many clinicians now treat weight management medicines the way they treat blood-pressure medication: ongoing, not a finite course. Your prescriber will weigh this up with you based on your individual circumstances, including whether the benefits continue to outweigh any side effects. There is a separate, detailed discussion of how long you can stay on Mounjaro that covers this in full.

It is worth knowing that the cost of Mounjaro over an extended period is a real consideration for anyone self-funding privately; understanding that upfront helps people plan rather than be surprised months in.

NICE's six-month review and what it means in practice

NICE's appraisal of tirzepatide (TA1026) sets a practical checkpoint: if someone has not lost at least 5% of their body weight after six months on the highest dose they can tolerate, continuing is reviewed. That is not a punitive rule; it is a recognition that not everyone responds to the same medicine in the same way, and that continuing without evidence of benefit is not in a patient's interest.

For the majority who do respond, there is no hard upper time limit in the UK licence itself. This is where private treatment differs meaningfully from the NHS route; on the NHS, access is still phased and subject to commissioning criteria, whereas a private prescriber can continue treatment for as long as it is clinically appropriate for you. The question of how long you should stay on Mounjaro ultimately comes back to a conversation with your prescriber, reviewed regularly.

People sometimes ask whether there is a point at which the medicine simply stops working. Plateaus are normal and expected; they do not necessarily signal treatment failure. Dose titration, lifestyle factors and individual biology all play a role, and our prescribers at nume's clinical team discuss this with patients as part of every repeat review.

Thinking about your own duration before you start

Going into treatment with a realistic picture of how long people typically continue is genuinely useful. It changes the financial planning, it changes the expectations around lifestyle work alongside treatment, and it changes how you interpret early results. The first pen at 2.5mg exists to help your body adjust, not to produce dramatic weight loss; the real therapeutic work builds as the dose increases over subsequent months.

Most people who find the medicine effective and tolerable end up staying on it for considerably longer than they initially expected. That is not a failure of planning; it is a reflection of how weight management actually works for many people. If you are ordering your pens, it is also worth reading about how long Mounjaro can be in transit, since understanding safe delivery windows helps you time orders sensibly and avoid gaps in treatment. For a detailed look at the first weeks, how long Mounjaro takes to work sets realistic expectations for what to look for early on.

If you are weighing up your weight-loss treatment options more broadly and wondering whether Mounjaro is the right fit, our prescribers review every consultation the same day it is submitted, a named clinician, not software. Check your eligibility by starting a free consultation with our clinical team.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions